CLIA: (Clinical Laboratory Improvement Amendments) are United States federal regulatory standards that apply to all clinical laboratory testing performed on humans in the United States, except clinical trials and basic research.
-
NOV 14, 2023 | 10:00 AM
C.E. CREDITS
Assessment for anti-dsDNA antibodies provides some of the most significant challenges in autoantibody serology testing. Anti-dsDNA antibodies are an important biomarker for systemic lupus er...
Date: April 19, 2022 Time: 10:00am (PDT), 1:00pm (EDT), 7:00pm (CEST) Once upon a time, there were three public health labs. These labs were busy serving their states when, out of nowhere, a...
APR 19, 2022 | 7:30 AM
C.E. CREDITS
While early genetic diagnosis can guide critical care management, the turnaround time for whole genome based diagnostic testing is months. Recent programs in neonatal populations have reduce...
Often overlooked but critical to most cannabis laboratory operations is sample workflow and sample preparation, having these areas figured out early in the start-up process is essential &nda...
This presentation “SARS-CoV-2 Related Workflow and Solutions: Detection and Genotyping” will focus on strategies for the testing and detection of SARS-CoV-2, including multiplexe...
Date: September 14, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Join us for a webinar to recalibrate your thinking on QC rules and runs, perhaps something you haven't done in like 10, 20, 30...
Date: August 11, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Quality can never be assumed, is never automatic, and requires the long-term commitment of the laboratory, staff, and manufacturers. L...
Date: April 21, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Serological testing for SARS-CoV-2 has been steadily adopted into clinical practice over the course of this pandemic. In this webinar,...
According to the American Cancer Society, in there were an estimated 110,070 new cases diagnosed and approximately 32,120 deaths from gynecologic cancers in the U.S. in 2018. Of the five mos...
This presentation will focus on strategies for the design and validation of robust assays for the detection of SARS-CoV-2, including nucleic acid extraction, multiplexed qPCR assays, and int...
Reliable diagnostic, prognostic, predictive, pharmacodynamic, and pharmacokinetic biomarkers are critical to assure correct patient selection, drug dosing, and monitoring. Being able to iden...